Cardiovascular and Renal Research Group, INCLIVA Research Institute, University of Valencia, Valencia, Spain.
Internal Medicine Hospital Clínico de Valencia, Valencia, Spain.
ESC Heart Fail. 2022 Dec;9(6):4230-4239. doi: 10.1002/ehf2.14124. Epub 2022 Sep 16.
The objective of the present study is to assess the bidirectional association between heart failure (HF) and atrial fibrillation (AF) using real-world data.
From an electronic health recording with a population of 3 799 885 adult subjects, those with prevalent or incident HF were selected and followed throughout a study period of 5 years. Prevalence and incidence of AF, and their impact in the risk for acute HF hospitalization, worsening renal function, ischaemic and haemorrhagic stroke, and all-cause mortality were identified. We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently analysed a subset of patients with incident HF and AF, 57 354 patients (S2). We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently a subset of patients with incident HF and AF, 57 354 patients (S2). The prevalence of AF was 59 906 (46.7%) of the HF patients, while incidence in the S2 was 231/1000 patients/year. In both cohorts, S1 and S2, AF significantly increases the risk of acute heart failure hospitalization [incidence 79.1/1000 and 97.5/1000 patients/year; HR 1.53 (1.48-1.59 95% CI) and HR 1.32 (1.24-1.41 95% CI), respectively], risk of decreased renal function (eGFR reduced by >20%) [66.2/1000 and 94.0/1000 patients/year; HR 1.13 (1.09-1.18 95% CI) and HR 1.22 (1.14-1.31 95% CI), respectively] and all-cause mortality [203/1000 and 294/1000 patients/year; HR 1.62 (1.58-1.65 95% CI) and HR 1.65 (1.59-1.70 95% CI), respectively]. The number of episodes of hospitalization for acute heart failure was also significantly higher in the AF patients (27 623 vs. 10 036, P < 0.001). However, the risk for ischaemic stroke was reduced in the AF subjects [HR 0.66 (0.63-0.74 95% CI)], probably due to the anticoagulant treatment.
AF is associated with an increment in the risk of episodes of acute heart failure as well as decline of renal function and increment of all-cause mortality.
本研究旨在使用真实世界数据评估心力衰竭(HF)和心房颤动(AF)之间的双向关联。
从一个拥有 3799885 名成年患者的电子健康记录中,选择了有或无HF的患者,并在 5 年的研究期间对其进行随访。确定了 AF 的患病率和发生率及其对急性 HF 住院、肾功能恶化、缺血性和出血性卒中和全因死亡率的风险的影响。我们分析了所有HF和AF的新发和现患患者,共 128086 例患者(S1),随后分析了 HF和AF的亚组患者,共 57354 例患者(S2)。我们分析了所有HF和AF的新发和现患患者,共 128086 例患者(S1),随后分析了 HF和AF的亚组患者,共 57354 例患者(S2)。HF 患者中 AF 的患病率为 59906 例(46.7%),而 S2 中的发病率为 231/1000 例/年。在两个队列(S1 和 S2)中,AF 显著增加了急性心力衰竭住院的风险[发病率为 79.1/1000 和 97.5/1000 例/年;HR 1.53(1.48-1.59,95%CI)和 HR 1.32(1.24-1.41,95%CI)],肾功能下降(eGFR 降低>20%)的风险[发病率为 66.2/1000 和 94.0/1000 例/年;HR 1.13(1.09-1.18,95%CI)和 HR 1.22(1.14-1.31,95%CI)],以及全因死亡率[发病率为 203/1000 和 294/1000 例/年;HR 1.62(1.58-1.65,95%CI)和 HR 1.65(1.59-1.70,95%CI)]。AF 患者的急性心力衰竭住院次数也明显更高(27623 次 vs. 10036 次,P<0.001)。然而,AF 患者的缺血性卒中风险降低(HR 0.66(0.63-0.74,95%CI)),这可能是由于抗凝治疗。
AF 与急性心力衰竭发作风险的增加、肾功能下降和全因死亡率的增加有关。